Upregulation of PD-1 on different subpopulation of the CD4+ and the CD8+ T cell subsets is widely described in CLL, where it generally correlates with an inferior disease outcome and increased risk of infection, independently of other prognostic markers [56,57]. Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.